Cargando…

Characteristics and Outcomes of Patients Consulted by a Multidisciplinary Pulmonary Embolism Response Team: 5-Year Experience

(1) Background: Pulmonary embolism (PE) is the third most frequent acute cardiovascular condition worldwide. PE response teams (PERTs) have been created to facilitate treatment implementation in PE patients. Here, we report on the 5-year experience of PERT operating in Warsaw, Poland, with regard to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pietrasik, Arkadiusz, Gąsecka, Aleksandra, Kurzyna, Paweł, Wrona, Katarzyna, Darocha, Szymon, Banaszkiewicz, Marta, Zieliński, Dariusz, Zajkowska, Dominika, Smyk, Julia Maria, Rymaszewska, Dominika, Jasińska, Karolina, Wasilewski, Marcin, Wolański, Rafał, Procyk, Grzegorz, Szwed, Piotr, Florczyk, Michał, Wróbel, Krzysztof, Grabowski, Marcin, Torbicki, Adam, Kurzyna, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9267516/ https://www.ncbi.nlm.nih.gov/pubmed/35807097 http://dx.doi.org/10.3390/jcm11133812

Ejemplares similares

Assessment of Clinical Usefulness of Resting Electrocardiogram (PH-ECG Score) in Monitoring the Efficacy of Balloon Pulmonary Angioplasty (BPA) in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Piłka, Michał, et al.
Publicado: (2021)

Circulating Blood-Based Biomarkers in Pulmonary Hypertension
por: Banaszkiewicz, Marta, et al.
Publicado: (2022)

An unusual case of CTEPH treated by BPA in a patient with a single lung after cancer surgery
por: Darocha, Szymon, et al.
Publicado: (2022)

Balloon Pulmonary Angioplasty with Stent Implantation as a Treatment of Proximal Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2020)

Hybrid treatment of massive pulmonary embolism by catheter-directed and surgical embolectomy
por: Pietrasik, Arkadiusz, et al.
Publicado: (2021)

Catheter-Based Therapies Decrease Mortality in Patients With Intermediate and High-Risk Pulmonary Embolism: Evidence From Meta-Analysis of 65,589 Patients
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Soluble ST2 as a Biomarker for Early Complications in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty
por: Banaszkiewicz, Marta, et al.
Publicado: (2021)

Emerging Role of Balloon Pulmonary Angioplasty in Chronic Thromboembolic Pulmonary Disease—Insights from the 2022 ESC Guidelines
por: Banaszkiewicz, Marta, et al.
Publicado: (2023)

Catheter-directed therapy to treat intermediate- and high-risk pulmonary embolism: Personal experience and review of the literature
por: Pietrasik, Arkadiusz, et al.
Publicado: (2022)

Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension
por: Kurzyna, Marcin, et al.
Publicado: (2015)

Prediction of Prognostic Hemodynamic Indices in Pulmonary Hypertension Using Non-Invasive Parameters
por: Mańczak, Rafał, et al.
Publicado: (2020)

Assessment of electrocardiographic markers of acute and long‐term hemodynamic improvement in patients with pulmonary hypertension
por: Piłka, Michał, et al.
Publicado: (2020)

Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension
por: Kacprzak, Aneta, et al.
Publicado: (2021)

Haemodynamic monitoring in acute heart failure – what you need to know
por: Jasińska-Gniadzik, Karolina, et al.
Publicado: (2022)

Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension
por: Darocha, Szymon, et al.
Publicado: (2021)

Expert opinion on the creating and operating of the regional Pulmonary Embolism Response Teams (PERT). Polish PERT Initiative
por: Araszkiewicz, Aleksander, et al.
Publicado: (2020)

Acute and chronic dissection of pulmonary artery: new challenges in pulmonary arterial hypertension?
por: Florczyk, Michał, et al.
Publicado: (2017)

Effect of Statins on All-Cause Mortality in Adults: A Systematic Review and Meta-Analysis of Propensity Score-Matched Studies
por: Nowak, Marcin M., et al.
Publicado: (2022)

Fear of COVID-19, Anxiety and Depression in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the Pandemic
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Catheter-directed mechanical aspiration thrombectomy in a real-world pulmonary embolism population: a multicenter registry
por: Sławek-Szmyt, Sylwia, et al.
Publicado: (2023)

Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension
por: Gąsecka, Aleksandra, et al.
Publicado: (2021)

Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors
por: Wieteska-Miłek, Maria, et al.
Publicado: (2022)

Dominating Cause of Pulmonary Hypertension May Change Over Time—Diagnostic and Therapeutic Considerations in a Patient with Pulmonary Hypertension Due to Rheumatoid Arthritis with Lung Involvement
por: Szturmowicz, Monika, et al.
Publicado: (2021)

In search of markers of treatment failure and poor prognosis in IPAH - the value of mosaic lung attenuation pattern on thin-section CT scans
por: Szturmowicz, Monika, et al.
Publicado: (2010)

COVID-19 Vaccination in Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Safety Profile and Reasons for Opting against Vaccination
por: Wieteska-Miłek, Maria, et al.
Publicado: (2021)

Topological Atomic Chains on 2D Hybrid Structure
por: Kwapiński, Tomasz, et al.
Publicado: (2021)

Antiplatelet effects of prostacyclin analogues: Which one to choose in case of thrombosis or bleeding?
por: Rogula, Sylwester P., et al.
Publicado: (2020)

Long COVID syndrome after SARS‐CoV‐2 survival in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
por: Wieteska‐Miłek, Maria, et al.
Publicado: (2023)

Complications following transcatheter edge-to-edge mitral valve repair: Personal experience and review of the literature
por: Maj, Dominik, et al.
Publicado: (2023)

Treatment of chronic thromboembolic pulmonary hypertension in a multidisciplinary team
por: Siennicka, Anna, et al.
Publicado: (2019)

Biomarker-based approach to determine etiology and severity of pulmonary hypertension: Focus on microRNA
por: Rogula, Sylwester, et al.
Publicado: (2022)

The multiple systemic artery to pulmonary artery fistulas resulting in severe irreversible pulmonary arterial hypertension in patient with previous history of pneumothorax
por: Jacheć, Wojciech, et al.
Publicado: (2019)

Roadmap towards an institutional Impella programme for high‐risk coronary interventions
por: Pietrasik, Arkadiusz, et al.
Publicado: (2023)

Extracellular Vesicles in Atrial Fibrillation—State of the Art
por: Procyk, Grzegorz, et al.
Publicado: (2022)

Autoantibodies in Atrial Fibrillation—State of the Art
por: Zygadło, Joanna, et al.
Publicado: (2023)

Plasma concentration of TMAO is an independent predictor of adverse outcomes in patients after acute myocardial infarction
por: Gąsecka, Aleksandra, et al.
Publicado: (2023)

Pregnancy as a predictor of deviations from the recommended diagnostic pathway in women with suspected pulmonary embolism: ZATPOL registry data
por: Fijałkowska, Anna, et al.
Publicado: (2017)

Effective Balloon Pulmonary Angioplasty in a Patient with Chronic Thromboembolic Complications after Ventriculoatrial Shunt for Hydrocephalus in von Hippel–Lindau Disease
por: Gościniak, Piotr, et al.
Publicado: (2022)

An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
por: Kurzyna, Marcin, et al.
Publicado: (2017)

The Four-Feature Prognostic Models for Cancer-Specific and Overall Survival after Surgery for Localized Clear Cell Renal Cancer: Is There a Place for Inflammatory Markers?
por: Zapała, Łukasz, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7spq52blrp6po5vjobvf252p8q